
Biofrontera Inc.: updates and filings
Price
$0.60
November 18, 2026Market cap $11M
What Ploutos Investor adds for Biofrontera
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 13, 2026next Feb 12, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
May 2026
March 2026
February 2026
January 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 13, 2026Results of operationsForm8-K
- Oct 30, 2026One of its securities removed from an exchange (usually a matured note)Form25-NSE
- Sep 14, 2026Other material eventsForm8-K
- Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 13, 2026Results of operationsForm8-K
- Aug 12, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 22, 2026Shares registered for employeesFormS-8
- Jul 22, 2026Annual report (amendment)for the period to Dec 31, 2025Form10-K/A
- Jun 17, 2026Shareholder voteForm8-K
- May 14, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 14, 2026Results of operationsForm8-K
- Apr 30, 2026Annual meeting proxy statementFormDEF 14A
- Mar 19, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 19, 2026Results of operationsForm8-K
- Mar 9, 2026Regulation FD disclosureForm8-K
- Feb 26, 2026Other material eventsForm8-K
- Feb 11, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 9, 2026Regulation FD disclosureForm8-K
- Jan 28, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 13, 2026Results of operationsForm8-K
- Jan 7, 2026Delisting noticeForm8-K
- Dec 19, 2025FilingFormEFFECT
- Dec 17, 2025Correspondence with the SECFormCORRESP
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 13, 2026 | 8-K | Results of operations | Document |
| Oct 30, 2026 | 25-NSE | One of its securities removed from an exchange (usually a matured note) | Document |
| Sep 14, 2026 | 8-K | Other material events | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 13, 2026 | 8-K | Results of operations | Document |
| Aug 12, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 22, 2026 | S-8 | Shares registered for employees | Document |
| Jul 22, 2026 | 10-K/A | Annual report (amendment)for the period to Dec 31, 2025 | Document |
| Jun 17, 2026 | 8-K | Shareholder vote | Document |
| May 14, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 14, 2026 | 8-K | Results of operations | Document |
| Apr 30, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 19, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 19, 2026 | 8-K | Results of operations | Document |
| Mar 9, 2026 | 8-K | Regulation FD disclosure | Document |
| Feb 26, 2026 | 8-K | Other material events | Document |
| Feb 11, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 9, 2026 | 8-K | Regulation FD disclosure | Document |
| Jan 28, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 13, 2026 | 8-K | Results of operations | Document |
| Jan 7, 2026 | 8-K | Delisting notice | Document |
| Dec 19, 2025 | EFFECT | Filing | Document |
| Dec 17, 2025 | CORRESP | Correspondence with the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 7, 2021.
The full analysis
What do Biofrontera's filings show?
The filings are where every one of Biofrontera's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.